Cardio Union, a leading private Chinese healthcare organization focused on the prevention and treatment of cardiology conditions, and The George Institute for Global Health, a leading medical and healthcare research organization addressing the prevention and management of major chronic diseases, today announced their collaboration in the creation of the Heart Health Research Center (HHRC) to help address the growing burden of cardiovascular disease in China and around the world. The new business entity will provide research services to deliver efficient, high quality and high impact research for customers focused on clinical, population and healthcare services for people at high risk of cardiovascular disease in China.
A new study published in The Lancet shows good progress has been made around the world in achieving some of the UN agreed global health goals, including reducing childhood mortality, providing family planning and the rollout of universal healthcare.
Looking after your heart starts with understanding your risk. To mark World Heart Day on 29 September, The George Institute China organised an event in the lobby of its office building to help people increase their health awareness by measuring their blood pressure / heart rhythm and promoting cardiovascular disease (CVD) prevention knowledge. What’s more, WeChat campaign named “What’s your rank” was carried out simultaneously to encourage people to be active and walk more.
The largest sleep study ever undertaken has found that the leading therapy for obstructive sleep apnea (OSA), Continuous Positive Airway Pressure (CPAP), does not reduce recurrent strokes and heart attacks in people with cardiovascular disease but does significantly improve their quality of life and mood.
The George Institute for Global Health, China (TGI China) today announced that world renowned clinician-scientist Professor Craig Anderson will be the new Executive Director for TGI China, taking over from Professor Zhi-Jie Zheng.
The safety of a controversial clot busting drug has been investigated by researchers at The George Institute for Global Health, with results showing a modified dosage can reduce serious bleeding in the brain and improve survival rates.